Sign in to continue:

Wednesday, July 29th, 2026

AXIS Capital Reports Strong Q2 2026 Results: Insurance Premiums Up, Combined Ratio at 90%




AXIS Capital Holdings Limited Reports Strong Q2 2026 Earnings

AXIS Capital Holdings Limited Delivers Robust Q2 2026 Results: Net Income and Book Value Surge

Key Financial Highlights for Investors

  • Q2 2026 net income available to common shareholders: \$251 million, up 16% from Q2 2025
  • Operating income: \$211 million for Q2 2026 (down 19% YoY)
  • Net income per diluted common share: \$3.38
  • Operating income per diluted common share: \$2.84
  • Annualized ROACE: 17.0%; Annualized operating ROACE: 14.3%
  • Combined ratio: 93.1%, delivering underwriting income of \$143 million
  • Book value per diluted common share: \$80.67, up \$2.48 (3.2%) from prior quarter and 14.7% YoY
  • For the first half of 2026: Net income available to common shareholders of \$498 million (up 24% YoY); operating income of \$468 million
  • Capital return to shareholders in Q2: \$122 million (share repurchases: \$89 million; dividends: \$33 million)
  • Significant reorganization expenses: \$29 million YTD to streamline operations and leadership transitions

Detailed Financial and Strategic Update

AXIS Capital Holdings Limited (“AXIS Capital”), a Bermuda-based specialty insurer and reinsurer, reported a strong performance for the second quarter and first half of 2026. The company’s Q2 results reflect robust profitability, continued book value growth, and active capital management.

Quarterly Performance

  • Net income available to common shareholders rose to \$251 million, compared to \$216 million in Q2 2025. This increase was driven by improved underwriting profitability and investment performance, partially offset by a decrease in operating income.
  • Operating income decreased to \$211 million from \$262 million in Q2 2025, reflecting higher expenses, including \$29 million in reorganization costs related to operational streamlining and executive leadership changes.
  • Combined ratio improved to 93.1%, resulting in \$143 million of underwriting income. The improvement highlights enhanced underwriting discipline and expense management. The underwriting-related general and administrative expense ratio decreased by 1.7 points due to higher net premiums earned.
  • Book value per diluted common share reached \$80.67, a sequential increase of \$2.48 (3.2%) and an impressive 14.7% increase over the past 12 months. The growth was primarily driven by net income, offset by share repurchases, dividends, and net unrealized investment losses.
  • Investment income remained robust, with net investment income of \$181.6 million in Q2 and \$366.3 million for the first half. The book yield on fixed maturities rose to 4.8%, with a market yield of 5.1% at quarter-end.
  • Capital management was a focus, with \$122 million returned to shareholders during the quarter, including \$89 million in share repurchases and \$33 million in dividends.

First Half 2026 Performance

  • Net income for the first six months of 2026 was \$498 million (\$6.67 per diluted share), up 24% year-over-year.
  • Operating income for the period came in at \$468 million (\$6.26 per diluted share).
  • Reorganization expenses were \$29 million, reflecting strategic initiatives to optimize the reinsurance platform and adjust the executive team.

Balance Sheet Strength

  • Total investments at June 30, 2026: \$16.6 billion
  • Shareholders’ equity: \$6.9 billion
  • Continued growth in book value per share, demonstrating AXIS Capital’s capacity to deliver shareholder value even as it invests in operational improvements and returns capital to shareholders.

Noteworthy and Potentially Price-Sensitive Developments

  • Strong book value and net income growth may positively influence investor sentiment and support the share price.
  • Improved underwriting profitability (combined ratio at 93.1%) signals effective risk selection and expense discipline, a key metric watched by shareholders and analysts.
  • Active share repurchases (\$89 million in Q2) and dividend payments (\$33 million) reinforce the company’s commitment to returning capital to shareholders, which is typically viewed favorably by the market.
  • Ongoing reorganization and expense management could drive future operating margin improvements, but also introduces some execution risk in the near term.
  • Investment returns remain solid, with book and market yields on fixed maturities rising, which may support future earnings if interest rates remain elevated.

Other Important Information for Shareholders

  • The company’s second quarter 2026 earnings conference call will be held on July 29, 2026 at 8:30 a.m. ET. Call-in and webcast details are available on the company’s investor relations website.
  • AXIS Capital has made available its Q2 2026 Investor Financial Supplement and updated investor presentation materials on its website for further review by investors and analysts.
  • Shareholders are reminded that the information in the 8-K filing is “furnished” and not “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, except as specifically incorporated by reference in future filings.

Conclusion

AXIS Capital Holdings Limited’s second quarter 2026 results demonstrate solid earnings momentum, disciplined underwriting, and strong capital returns to shareholders. The improvement in book value, profitability metrics, and ongoing capital management initiatives are all positive indicators. However, investors should also monitor the impact of reorganization expenses and execution of operational changes, which could influence future results.


Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any securities. Investors should review the full financial statements and disclosures and consult with their financial advisors before making investment decisions. The information is based on public filings and company disclosures as of the date of this article and may be subject to change.




View AXIS CAPITAL HOLDINGS LTD Historical chart here



MoonLake Immunotherapeutics Announces Positive FDA Pre-BLA Meeting and Reports Q1 2026 Financial Results

MoonLake Immunotherapeutics Reports Positive FDA Pre-BLA Mee...

InnSuites Hospitality Trust 2026 Annual Report: Hotel Performance, Strategic Growth & NYSE Listing

InnSuites Hospitality Trust: 2026 Annual Report (10-K/A) - K...